Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE’s STAT-Net

Innovations are urgently required for clinical development of antibacterials against multidrug-resistant organisms. Therefore, a European, public-private working group (STAT-Net; part of Combatting Bacterial Resistance in Europe [COMBACTE]), has reviewed and tested several innovative trials designs...

Descripción completa

Detalles Bibliográficos
Autores principales: de Kraker, Marlieke E A, Sommer, Harriet, de Velde, Femke, Gravestock, Isaac, Weiss, Emmanuel, McAleenan, Alexandra, Nikolakopoulos, Stavros, Amit, Ohad, Ashton, Teri, Beyersmann, Jan, Held, Leonhard, Lovering, Andrew M, MacGowan, Alasdair P, Mouton, Johan W, Timsit, Jean-François, Wilson, David, Wolkewitz, Martin, Bettiol, Esther, Dane, Aaron, Harbarth, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260160/
https://www.ncbi.nlm.nih.gov/pubmed/30107400
http://dx.doi.org/10.1093/cid/ciy516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260160/
https://www.ncbi.nlm.nih.gov/pubmed/30107400
http://dx.doi.org/10.1093/cid/ciy516

Ejemplares similares